Your browser doesn't support javascript.
loading
[Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].
Xu, Li; Luo, Long-Ze; Zhu, Bing-Qing; He, Li; Gao, Yuan; Shao, Zhu-Jun.
Afiliação
  • Xu L; State Key Laboratory for Infectious Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 30(6): 619-21, 2009 Jun.
Article em Zh | MEDLINE | ID: mdl-19957632
ABSTRACT

OBJECTIVE:

To optimize the serum bactericidal assay (SBA), detect and analyze the bactericidal antibody level against Neisseria meningitidis serogroup C strains after divalent polysaccharide (A plus C) vaccine immunization.

METHODS:

Two Neisseria meningitidis serogroup C strains, vaccine candidate strain (C11) and epidemic strain (053442), were selected as targets. The national Neisseria meningitidis standardized serum was used as reference serum. Pel-Freez infant rabbit complements was available. The optimized SBA method was used to detect bactericidal antibody against strain C11 and 053442 for 122 pairs of sera before and after immunization with a divalent polysaccharide (A and C) vaccine.

RESULTS:

The strain C11 and 053442 both could be used as targeted strain for SBA. The optimized concentration of targeted strain was achieved when a whole-cell suspension of 0.35 A at 600 nm was diluted 4 x 10(4) times. Before immunization, SBA geometric mean titers (GMT) of 122 sera against strain C11 and 053442 were 11.75 and 12.63 respectively, and the protective rates were 9.8% and 17.2% respectively. After immunization, the GMTs and the protective rates of 122 sera both rose significantly (P<0.01), the GMTs against strain C11 and 053442 were 1483.73 and 1412.57 respectively. The protective rates against strain C11 and 053442 were 100% and 95.9% respectively.

CONCLUSION:

Immunization with a divalent polysaccharide (A and C) vaccine could elevate remarkably the population SBA titer against Neisseria meningitidis serogroup C strains of different subtypes, but the surveillance of vaccine effect against different targeted strains remains necessary.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo C / Anticorpos Antibacterianos Limite: Animals Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Ano de publicação: 2009 Tipo de documento: Article País de afiliação: China
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Meningocócicas / Neisseria meningitidis Sorogrupo C / Anticorpos Antibacterianos Limite: Animals Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Ano de publicação: 2009 Tipo de documento: Article País de afiliação: China